Kamata, S.; Honda, A.; Ishikawa, R.; Akahane, M.; Fujita, A.; Kaneko, C.; Miyawaki, S.; Habu, Y.; Shiiyama, Y.; Uchii, K.;
et al. Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. Antioxidants 2023, 12, 1523.
https://doi.org/10.3390/antiox12081523
AMA Style
Kamata S, Honda A, Ishikawa R, Akahane M, Fujita A, Kaneko C, Miyawaki S, Habu Y, Shiiyama Y, Uchii K,
et al. Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. Antioxidants. 2023; 12(8):1523.
https://doi.org/10.3390/antiox12081523
Chicago/Turabian Style
Kamata, Shotaro, Akihiro Honda, Ryo Ishikawa, Makoto Akahane, Ayane Fujita, Chihiro Kaneko, Saeka Miyawaki, Yuki Habu, Yui Shiiyama, Kie Uchii,
and et al. 2023. "Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor" Antioxidants 12, no. 8: 1523.
https://doi.org/10.3390/antiox12081523
APA Style
Kamata, S., Honda, A., Ishikawa, R., Akahane, M., Fujita, A., Kaneko, C., Miyawaki, S., Habu, Y., Shiiyama, Y., Uchii, K., Machida, Y., Oyama, T., & Ishii, I.
(2023). Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. Antioxidants, 12(8), 1523.
https://doi.org/10.3390/antiox12081523